"For over 100 years, the highly skilled professionals of Elkhart General Hospital have been providing comprehensive medical care to Elkhart and surrounding communities. We are a patient-first health care organization whose ongoing mission is to help create healthier communities throughout Michiana. We carry out that mission one patient at a time. One family at a time. We carry out that mission by always putting our patients’ needs first. And it's not just a motto. We measure our services to all our patients through a formal satisfaction survey process. The results of the survey are shared throughout the organization."

During the past decade, Elkhart General Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 146 clinical trials were completed, i.e. on average, 4866.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 26 clinical trials were completed. i.e. 2600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Elkhart General Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 77 trials, followed by "National Cancer Institute (NCI)" with 66 trials sponsored, "Eastern Cooperative Oncology Group" with 20 trials sponsored, "Gynecologic Oncology Group" with 18 trials sponsored and "SWOG Cancer Research Network" with 18 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elkhart General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 166 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "NCIC Clinical Trials Group" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator and "SWOG Cancer Research Network" with 15 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Elkhart General Hospital" are "Breast Cancer" (41 trials), "Lung Cancer" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (16 trials), "Colorectal Cancer" (11 trials) and "Lymphoma" (11 trials). Many other conditions were trialed in "Elkhart General Hospital" in a lesser frequency.

Most popular intervention types in "Elkhart General Hospital" are "Drug" (195 trials), "Other" (116 trials), "Biological" (78 trials), "Radiation" (40 trials) and "Procedure" (35 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Quality-of-Life Assessment" (36 trials), "placebo" (32 trials), "Paclitaxel" (27 trials) and "Bevacizumab" (22 trials). Other intervention names were less common.

The vast majority of trials in "Elkhart General Hospital" are 160 trials for "All" genders, 74 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Elkhart General Hospital". undefined are not yet recruiting, 3 are recruiting, 60 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 154 completed trials in Elkhart General Hospital, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Elkhart General Hospital, 6 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 128 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".